IGFBP5 and diabetic kidney disease: Our study confirms a new proinflammatory role of IGFBP5 in the pathogenesis of DKD through PFKFB3, suggesting that IGFBP5 may be a promising target for the treatment of DKD to inhibit early inflammatory responses and delay DKD progression.